GE Healthcare (NYSE: GE) announced interim results of a recently completed randomized study of the impact of DaTscan SPECT imaging ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE